Tokushima, Japan

Noriyuki Kobayashi

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 19.0

ph-index = 5

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: **Innovator Noriyuki Kobayashi: Pioneering Low Hygroscopic Drug Substances**

Introduction

Noriyuki Kobayashi is a prominent inventor based in Tokushima, Japan. With a significant portfolio of 12 patents, he has made substantial contributions to the field of pharmaceutical science, particularly focusing on innovative drug substances.

Latest Patents

Among his latest patents, Kobayashi has developed a low hygroscopic aripiprazole drug substance. This invention provides low hygroscopic forms of aripiprazole along with processes for its preparation. The significance of this invention lies in its ability to maintain solubility without converting to a hydrate, even when stored for extended periods. This advancement can greatly enhance the stability and efficacy of medicinal preparations containing anhydrous aripiprazole crystals.

Career Highlights

Throughout his career, Kobayashi has been associated with notable companies, including Otsuka Pharmaceutical Company and Otsuka Pharmaceutical Co. Ltd. His work at these organizations has allowed him to develop innovative solutions that address key challenges in the pharmaceutical industry.

Collaborations

Kobayashi has also collaborated with esteemed colleagues, including Takuji Bando and Satoshi Aoki. These partnerships have fostered a creative environment that encourages the development of breakthrough inventions in drug formulation and delivery.

Conclusion

Noriyuki Kobayashi's contributions to pharmaceutical innovations through his patents, particularly in low hygroscopic drug substances, highlight his role as a key inventor in the industry. His ongoing work continues to impact the field positively, paving the way for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…